Literature DB >> 9605448

Fetal plasma levels of circulating endothelial cell adhesion molecules in normal and preeclamptic pregnancies.

T Krauss1, H Azab, M Dietrich, H G Augustin.   

Abstract

OBJECTIVE: Circulating levels of endothelial cell adhesion molecules are elevated in women with preeclampsia. The aim of the present study was to determine levels of these molecules in the fetal circulation of normal pregnancies and pregnancies complicated by preeclampsia. STUDY
DESIGN: Fetal plasma samples from the umbilical vein and peripheral maternal plasma and serum sample were collected at delivery from women with preeclampsia and women with normal pregnancy. Women with non-proteinuric pregnancy-induced hypertension (PIH) were excluded from the study. A sandwich ELISA technique was employed to quantitate concentrations of soluble ICAM-1 (CD54), VCAM-1 (CD106), and E-selectin (CD62E).
RESULTS: The normal values of soluble endothelial cell adhesion molecules in the fetal circulation were determined as 162+/-45 ng/ml for ICAM-1, 1612+/-582 ng/ml for VCAM-1, and 154+/-58 ng/ml for E-selectin. They were found to markedly differ from the corresponding normal values in the maternal circulation (sICAM-1: 247+/-65 ng/ml; sVCAM-1: 715+/-170 ng/ml; sE-selectin: 34+/-14 ng/ml). The concentrations of sICAM-1, sVCAM-1, and sE-selectin were significantly elevated in women with preeclampsia compared to healthy control pregnant women. In contrast, there was no difference in the circulating fetal concentrations of these molecules between normal pregnancies and pregnancies complicated by preeclampsia.
CONCLUSIONS: Normal values of sICAM-1, sVCAM-1, and sE-selectin in fetal circulation are markedly different from the values obtained for healthy adults. Plasma concentrations of these molecules are elevated in women with preeclampsia but not in the fetal circulation of preeclamptic pregnancies suggesting that based on the analysis of soluble adhesion molecules the fetal circulation may not be affected by the factor(s) that lead to disturbed endothelial cell function in women with preeclampsia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605448     DOI: 10.1016/s0301-2115(98)00010-4

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  6 in total

1.  A comparative study of vascular cell adhesion molecule-1 and high-sensitive C-reactive protein in normal and preeclamptic pregnancies.

Authors:  Mehdi Farzadnia; Hossein Ayatollahi; Maliheh Hasan-Zade; Hamid Reza Rahimi
Journal:  Interv Med Appl Sci       Date:  2013-03-19

2.  A Comparative Study of Serum Level of Vascular Cell Adhesion Molecule-1 (sVCAM-1), Intercellular Adhesion Molecule-1(ICAM-1) and High Sensitive C - reactive protein (hs-CRP) in Normal and Pre-eclamptic Pregnancies.

Authors:  Mehdi Farzadnia; Hossein Ayatollahi; Maliheh Hasan-Zade; Hamid Reza Rahimi
Journal:  Iran J Basic Med Sci       Date:  2013-05       Impact factor: 2.699

3.  Therapeutic effects of umbilical cord blood plasma in a rat model of acute ischemic stroke.

Authors:  Jongman Yoo; Han-Soo Kim; Jin-Ju Seo; Jang-Hyoun Eom; Seong-Mi Choi; Sanghyun Park; Dong-Wook Kim; Dong-Youn Hwang
Journal:  Oncotarget       Date:  2016-11-29

4.  Maternal, Fetal, and Placental Selectins in Women With Pre-eclampsia; Association With the Renin-Angiotensin-System.

Authors:  Hiten D Mistry; Melissa V Hott Ogalde; Fiona Broughton Pipkin; Geneviève Escher; Lesia O Kurlak
Journal:  Front Med (Lausanne)       Date:  2020-06-12

5.  Chemerin Effect on the Endometrial Proteome of the Domestic Pig during Implantation Obtained by LC-MS/MS Analysis.

Authors:  Kinga Orzechowska; Kamil Dobrzyń; Marta Kieżun; Agata Malinowska; Bianka Świderska; Tadeusz Kamiński; Nina Smolińska
Journal:  Cells       Date:  2022-03-30       Impact factor: 6.600

6.  Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia.

Authors:  Shin-Young Kim; Hyun-Mee Ryu; Jae Hyug Yang; Moon-Young Kim; Hyun-Kyong Ahn; Ha-Jung Lim; Joong-Sik Shin; Hyuk-Jun Woo; So-Yeon Park; Young-Mi Kim; Jin-Woo Kim; Eun Hee Cho
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.